氟西汀治疗焦虑和抑郁障碍共病的对照研究  

A contral study of fluoxetine in the treatment of comorbid depression anxiety

作　　者：程继东[1] 张丽[1] 

机构地区：[1]江苏丰县中医院,江苏丰县221700

出　　处：《吉林医学》2010年第30期5279-5280,共2页Jilin Medical Journal

摘　　要：目的:探讨氟西汀对焦虑和抑郁障碍共病的疗效及安全性。方法:口服氟西汀和阿米替林各治疗35例,疗程8周,用焦虑自评量表(SAS)、抑郁自评量表(SDS)和不良反应量表(TESS)进行评定。结果:氟西汀与阿米替林的疗效相当,但氟西汀对惊恐发作、强迫症和恐怖症与抑郁症共病的疗效好于阿米替林,而对广泛性焦虑与抑郁症共病的疗效不如阿米替林,但不良反应比阿米替林明显少而轻。结论:氟西汀是较理想的治疗焦虑和抑郁障碍共病的药物。Objective To explore the efficacy and side effects of fluoxetine in the treatment of comorbid depression anxiety.Methods 35 patients were treated with fluoxetine.The efficacy was measured with Self-Rating Anxiety Scale and Self-Rating Depression Scale.Results Fluoxetine possessed efficacy similar to that of amitriptyline,but the side effects of fluoxetine were fewer and milder than amitriptyline. Conclusion Fluoxetine is an appropriated drug in the treament of comorbid depression anxiety.

关 键 词：氟西汀 焦虑障碍 抑郁症 

分 类 号：R749.4[医药卫生—神经病学与精神病学]